Investigación / Grupos de investigación

Grupo  401

Microbiología clínica y enfermedades Infecciosas

Publicaciones (1284)

  • Bassetti, M; Marchetti, M; Chakrabarti, A; Colizza, S; Garnacho-Montero, J; Kett, D; Munoz, P; Cristini, F; Andoniadou, A; Viale, P; Della Rocca, G; Roilides, E; Sganga, G; Walsh, T; Tascini, C; Tumbarello, M; Menichetti, F; Righi, E; Eckmann, C; Viscoli, C; Shorr, A; Leroy, O; Petrikos, G; De Rosa, FG.

    A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts

    INTENSIVE CARE MEDICINE. 2013; 39(12): 2092-2106 Nº de citas: 159 [doi:10.1007/s00134-013-3109-3]

  • Espinel-Ingroff, A; Arendrup, MC; Pfaller, MA; Bonfietti, LX; Bustamante, B; Canton, E; Chryssanthou, E; Cuenca-Estrella, M; Dannaoui, E; Fothergill, A; Fuller, J; Gaustad, P; Gonzalez, GM; Guarro, J; Lass-Florl, C; Lockhart, SR; Meis, JF; Moore, CB; Ostrosky-Zeichner, L; Pelaez, T; Pukinskas, SRBS; St-Germain, G; Szeszs, MW; Turnidge, J.

    Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2013; 57(12): 5836-5842 Nº de citas: 192 [doi:10.1128/AAC.01519-13]

  • Alonso, M; Martinez-Lirola, M; Palacios, JJ; Menendez, A; Herranz, M; Martinez, S; Bouza, E; Garcia-de-Viedma, D.

    Evaluation of the potential role of a new mutation in mabA in modifying the response of Mycobacterium tuberculosis to isoniazid

    Tuberculosis. 2013; 93(6): 664-667 Nº de citas: 1 [doi:10.1016/j.tube.2013.07.003]

  • Gasch, O; Camoez, M; Dominguez, MA; Padilla, B; Pintado, V; Almirante, B; Molina, J; Lopez-Medrano, F; Ruiz, E; Martinez, JA; Bereciartua, E; Rodriguez-Lopez, F; Fernandez-Mazarrasa, C; Goenaga, MA; Benito, N; Rodriguez-Bano, J; Espejo, E; Pujol, M.

    Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy

    CLINICAL MICROBIOLOGY AND INFECTION. 2013; 19(11): 1049-1057 Nº de citas: 66 [doi:10.1111/1469-0691.12108]

  • Lanzarot, P; Blanco, JL; Alvarez-Perez, S; Abad, C; Cutuli, MT; Garcia, ME.

    Prolonged fecal shedding of 'megabacteria' (Macrorhabdus ornithogaster) by clinically healthy canaries (Serinus canaria)

    MEDICAL MYCOLOGY. 2013; 51(8): 888-891 Nº de citas: 13 [doi:10.3109/13693786.2013.813652]

  • Rodriguez-Campos, S; Navarro, Y; Romero, B; de Juan, L; Bezos, J; Mateos, A; Golby, P; Smith, NH; Hewinson, GR; Dominguez, L; Garcia-de-Viedma, D; Aranaz, A.

    Splitting of a Prevalent Mycobacterium bovis Spoligotype by Variable-Number Tandem-Repeat Typing Reveals High Heterogeneity in an Evolving Clonal Group

    JOURNAL OF CLINICAL MICROBIOLOGY. 2013; 51(11): 3658-3665 Nº de citas: 31 [doi:10.1128/JCM.01271-13]

  • Rojas, L; Munoz, P; Kestler, M; Arroyo, D; Guembe, M; Rodriguez-Creixems, M; Verde, E; Bouza, E.

    Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality

    Journal of Hospital Infection. 2013; 85(3): 196-205 Nº de citas: 38 [doi:10.1016/j.jhin.2013.07.009]

  • Marcos-Zambrano, LJ; Escribano, P; Rueda, C; Zaragoza, O; Bouza, E; Guinea, J.

    Comparison between the EUCAST Procedure and the Etest for Determination of the Susceptibility of Candida Species Isolates to Micafungin

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2013; 57(11): 5767-5770 Nº de citas: 17 [doi:10.1128/AAC.01032-13]

  • Munoz, P; Valerio, M; Palomo, J; Giannella, M; Yanez, JF; Desco, M; Bouza, E.

    Targeted Antifungal Prophylaxis in Heart Transplant Recipients

    TRANSPLANTATION. 2013; 96(7): 664-669 Nº de citas: 42 [doi:10.1097/TP.0b013e31829e6d7b]

  • Alvarez-Perez, S; de Vega, C; Herrera, CM.

    Multilocus Sequence Analysis of Nectar Pseudomonads Reveals High Genetic Diversity and Contrasting Recombination Patterns

    PLoS One. 2013; 8(10): Nº de citas: 21 [doi:10.1371/journal.pone.0075797]

  • Horcajada, JP; Shaw, E; Padilla, B; Pintado, V; Calbo, E; Benito, N; Gamallo, R; Gozalo, M; Rodriguez-Bano, J.

    Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance

    CLINICAL MICROBIOLOGY AND INFECTION. 2013; 19(10): 962-968 Nº de citas: 106 [doi:10.1111/1469-0691.12089]

  • Forastiero, A; Mesa-Arango, AC; Alastruey-Izquierdo, A; Alcazar-Fuoli, L; Bernal-Martinez, L; Pelaez, T; Lopez, JF; Grimalt, JO; Gomez-Lopez, A; Cuesta, I; Zaragoza, O; Mellado, E.

    Candida tropicalis Antifungal Cross-Resistance Is Related to Different Azole Target (Erg11p) Modifications

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2013; 57(10): 4769-4781 Nº de citas: 110 [doi:10.1128/AAC.00477-13]

  • Escribano, P; Guinea, J; Marcos-Zambrano, L; Recio, S; Pelaez, T; Rodriguez-Creixems, M; Munoz, P; Bouza, E.

    Does identification to species level provide sufficient evidence to confirm catheter-related fungemia caused by Candida albicans?

    MEDICAL MYCOLOGY. 2013; 51(7): 769-773 Nº de citas: 6 [doi:10.3109/13693786.2013.803165]

  • Alvarez-Perez, S; Blanco, JL; Pelaez, T; Astorga, RJ; Harmanus, C; Kuijper, E; Garcia, ME.

    High prevalence of the epidemic Clostridium difficile PCR ribotype 078 in Iberian free-range pigs

    RESEARCH IN VETERINARY SCIENCE. 2013; 95(2): 358-361 Nº de citas: 28 [doi:10.1016/j.rvsc.2013.06.021]

  • Lalani, T; Chu, VH; Park, LP; Cecchi, E; Corey, GR; Durante-Mangoni, E; Fowler, VG; Gordon, D; Grossi, P; Hannan, M; Hoen, B; Munoz, P; Rizk, H; Kanj, SS; Selton-Suty, C; Sexton, DJ; Spelman, D; Ravasio, V; Tripodi, MF; Wang, A.

    In-Hospital and 1-Year Mortality in Patients Undergoing Early Surgery for Prosthetic Valve Endocarditis

    JAMA Internal Medicine. 2013; 173(16): 1495-1504 Nº de citas: 229 [doi:10.1001/jamainternmed.2013.8203]

  • Santos, ID; Gomez-Berrocal, A; Valencia, E; Asensi, V; Gijon, P; Moreno, V; Vergas, J; Bernardino, I.

    Efficacy and Tolerability of Darunavir/Ritonavir in Combination with Abacavir/Lamivudine: An Option in Selected HIV-Infected Patients

    HIV CLINICAL TRIALS. 2013; 14(5): 254-259 Nº de citas: 1 [doi:10.1310/hct1405-254]

  • Bouza, E; Marin, M; Pelaez, T; Alcala, L.

    The situation and management of Clostridium difficile infection in Spain: an opinion document

    Revista Espanola de Quimioterapia. 2013; 26(3): 261-286 Nº de citas: 10

  • Bouza, E; Granda, MJP; Hortal, J; Barrio, JM; Cercenado, E; Munoz, P.

    Pre-emptive broad-spectrum treatment for ventilator-associated pneumonia in high-risk patients

    INTENSIVE CARE MEDICINE. 2013; 39(9): 1547-1555 Nº de citas: 32 [doi:10.1007/s00134-013-2997-6]